SMTI Stock Price Chart
SMTI Earnings
Sanara Medtech Inc
$19.51
2.73%
$0.52
As of today:May 01, 13:31:03 GMT-4
Back
Sanara Medtech Inc (SMTI) Earnings
Latest Earnings Results: Q4 '25
Reported: 2026-03-24
Historical Earnings
Quarterly
Annual
EPS
Revenue
Earnings FAQ
How did SMTI's recent EPS compare to expectations?
How did Sanara Medtech Inc SMTI's revenue perform in the last quarter?
What is the revenue estimate for Sanara Medtech Inc?
What's the earning quality score for Sanara Medtech Inc?
When does Sanara Medtech Inc report earnings?
What are Sanara Medtech Inc's expected earnings?
Did Sanara Medtech Inc beat earnings expectations?
Key Stats
Prev.Close
$18.99
Open
$18.61
Day's Range
$18.61 - $19.51
52 week range
$16.46 - $35.95
Volume
3.5K
Avg.Volume
58.9K
Dividend yield
--
EPS (TTM)
-4.35
Market Cap
$178.9M
What is SMTI?
Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. The company is headquartered in Fort Worth, Texas and currently employs 141 full-time employees. The company markets several products for surgical and chronic wound care applications and has multiple products in its pipeline. Its surgical products, CellerateRX Surgical, TEXAGEN, BiFORM, ACTIGEN, ALLOCYTE, ALLOCYTE Plus Advanced Viable Bone Matrix (ALLOCYTE Plus), BIASURGE, FORTIFY TRG Tissue Repair Graft (FORTIFY TRG), and FORTIFY FLOWABLE Extracellular Matrix (FORTIFY FLOWABLE) are used in a range of surgical specialties to help promote patient healing and reduce the risk of complications. CellerateRX Surgical products, TEXAGEN products, FORTIFY TRG and FORTIFY FLOWABLE are used in specialties, including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, and others.
